These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2875481

  • 1. Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate.
    Szukalski B, Lipska B, Welbel L, Nurowska K.
    Psychopharmacology (Berl); 1986; 89(4):428-31. PubMed ID: 2875481
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Zuclopenthixol decanoate in schizophrenia: serum levels and clinical state.
    Jørgensen A, Aaes-Jørgensen T, Gravem A, Amthor KF, Dencker SJ, Rosell I, Baastrup PC, Buckhave J, Gram LF.
    Psychopharmacology (Berl); 1985; 87(3):364-7. PubMed ID: 2867572
    [Abstract] [Full Text] [Related]

  • 4. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
    Borsetti G, Rocco P, Spilimbergo PG, Giavedoni A, Frangiamone L, Beccaceci A, Judice A, Cisternino M, Volterra V.
    Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
    Jaanson P, Marandi T, Kiivet RA, Vasar V, Vään S, Svensson JO, Dahl ML.
    Psychopharmacology (Berl); 2002 Jun; 162(1):67-73. PubMed ID: 12107620
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A, Ba B, Durand A, Gouezo F, Hou N, Jørgensen A.
    Psychopharmacology (Berl); 1988 Jun; 94(3):293-7. PubMed ID: 2895936
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
    Izmeth MG, Khan SY, Kumarajeewa DI, Shivanathan S, Veall RM, Wiley YV.
    Pharmatherapeutica; 1988 Jun; 5(4):217-27. PubMed ID: 2902642
    [Abstract] [Full Text] [Related]

  • 13. Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study.
    Wistedt B, Koskinen T, Thelander S, Nerdrum T, Pedersen V, Mølbjerg C.
    Acta Psychiatr Scand; 1991 Jul; 84(1):14-21. PubMed ID: 1681680
    [Abstract] [Full Text] [Related]

  • 14. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
    Sieberns S, Spechtmeyer H.
    Int Pharmacopsychiatry; 1982 Jul; 17(3):170-84. PubMed ID: 7141812
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients: a single-dose preliminary study.
    Tan CH, Low BL, Ng LL, Khoo YM, Lee HS.
    Ther Drug Monit; 1993 Apr; 15(2):108-12. PubMed ID: 8099240
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of three different injectable zuclopenthixol preparations.
    Aaes-Jørgensen T.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 Apr; 13(1-2):77-85. PubMed ID: 2568662
    [Abstract] [Full Text] [Related]

  • 19. Zuclopenthixol decanoate in maintenance treatment of schizophrenic outpatients. Minimum effective dose and corresponding serum levels.
    Solgaard T, Kistrup K, Aaes-Jørgensen T, Gerlach J.
    Pharmacopsychiatry; 1994 May; 27(3):119-23. PubMed ID: 8078952
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.